---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-008902"
form_type: "8-K"
ticker: "NTHI"
cik: "0001979414"
company_name: "NEONC TECHNOLOGIES HOLDINGS, INC."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:02:59.292145+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeOnc Technologies appoints Amir Heshmatpour as CEO; founder Dr. Thomas Chen transitions to CMO/CSO

## Summary
- Dr. Thomas Chen resigns as CEO, becomes Chief Medical Officer and Chief Scientific Officer, retains Vice Chairman role.
- Amir Heshmatpour appointed CEO effective Oct 31, 2025, in addition to President and Executive Chairman roles.
- Heshmatpour to receive $1/year salary and 1.2M restricted stock shares with vesting schedule.
- Press release highlights $50M strategic partnership with Quazar Investment and expansion of Scientific Advisory Board.

## SEC filing metadata
- accession: 0001829126-25-008902
- form_type: 8-K
- ticker: NTHI
- cik: 0001979414
- company_name: NEONC TECHNOLOGIES HOLDINGS, INC.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008902/0001829126-25-008902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008902/neonctechnologies_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-008902
- JSON: https://secwatch.observer/filing/0001829126-25-008902.json
- Plain text: https://secwatch.observer/filing/0001829126-25-008902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.